Preston Ngo
Postdoctoral Scientist
Cancer Surveillance
Speciality: Health economics, cancer epidemiology, biostatistics
| Year | Degree | Major | Institution | Country/Town |
|---|---|---|---|---|
| 2021 | Doctor of Philosophy | Costs and quality-of-life | University of Sydney | Australia / Sydney |
Current Research Projects
Global cost of cancer
Selected Publications
Preston Ngo, Deme Karikios, David Goldsbury, et al. 2023. Development and Validation of txSim: A Model of Advanced Lung Cancer Treatment in Australia. Pharmacoeconomics, Vol 41 1525-1537
Silvia Behar-Harpaz, Marianne Weber, Stephen Wade et al. 2022. Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomes. British Journal of Cancer, Vol 128 91-101
Preston Ngo, Sonya Cressman, Silvia Behar-Harpaz et al. Applying utility values in cost-effectiveness analyses of lung cancer screening: A review of methods. Lung Cancer, Vol 166 122-131
Preston Ngo, Stephen Wade, Emily Banks, et al. 2022. Large-Scale Population-Based Surveys Linked to Administrative Health Databases as a Source of Data on Health Utilities in Australia. Value in Health, Vol 25, Issue 9 1634-1643
Preston Ngo, David Goldsbury, Deme Karikios, et al. 2021. Lung cancer treatment patterns and factors relating to systemic therapy use in Australia. Asia-Pacific Journal of Clinical Oncology, Vol 18, Issue 5 e235-e246